TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24 20:47 | 5/6/24 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | M.d | 0 | 0.00 | 0 | 41 | 170 | 65 | D | |||||||||||||||
6/20/23 16:16 | 6/17/23 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | M.d | 0 | 0.00 | 0 | 15 | 158 | 24 | D | |||||||||||||||
6/17/22 17:09 | 6/16/22 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | M.d | 0 | 0.00 | 0 | 4 | 71 | 9 | D | |||||||||||||||
10/21/21 16:29 | 8/16/21 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | S.a | -140 | 55.82 | 0 | -3 | -31 | 6 | D | |||||||||||||||
9/15/21 16:35 | 9/13/21 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | M.d | 58 | 19.33 | 0 | 3 | 85 | 7 | D | |||||||||||||||
9/15/21 16:35 | 9/13/21 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malloy Kirk | WA | D | S.d | -178 | 59.37 | 0 | -3 | -32 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |